FaundesV, JenningsMD, CrillyS, et al.Impaired eIF5A function causes a Mendelian disorder that is partially rescued in model systems by spermidine. Nat Commun, 2021; 12(1):833.
2.
ManjunathH, ZhangH, RehfeldF, et al.Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection. Cell Rep, 2019; 29(10):3134–3146.e6.
3.
SchullerAP, WuCC-C, DeverTE, et al.eIF5A functions globally in translation elongation and termination. Mol Cell, 2017; 66(2):194–205.e5.
4.
HoqueM, ParkJY, ChangYJ, et al.Regulation of gene expression by translation factor eIF5A: Hypusine-modified eIF5A enhances nonsense-mediated mRNA decay in human cells. Translation (Austin), 2017; 5(2):e1366294.
5.
SainiP, EylerDE, GreenR, et al.Hypusine-containing protein eIF5A promotes translation elongation. Nature, 2009; 459(7243):118–121.
6.
PálfiP, BakacsyL, KovácsH, et al.Hypusination, a metabolic posttranslational modification of eIF5A in plants during development and environmental stress responses. Plants, 2021; 10(7):1261.
7.
NishimuraK, LeeSB, ParkJH, et al.Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development. Amino Acids, 2012; 42(2–3):703–710.
8.
ParkMH, NishimuraK, ZanelliCF, et al.Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids, 2010; 38(2):491–500.
9.
IvanovIP, ShinBS, LoughranG, et al.Polyamine control of translation elongation regulates start site selection on antizyme inhibitor mRNA via ribosome queuing. Mol Cell, 2018; 70(2):254–264 e6.
10.
GutierrezE, ShinBS, WoolstenhulmeCJ, et al.eIF5A promotes translation of polyproline motifs. Mol Cell, 2013; 51(1):35–45.
11.
LiA-L, LiH-Y, JinB-F, et al.A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem, 2004; 279(47):49251–49258.
12.
TaylorCA, SunZ, ClicheDO, et al.Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor α signalling. Exp Cell Res, 2007; 313(3):437–449.
13.
HavrillaJM, PedersenBS, LayerRM, et al.A map of constrained coding regions in the human genome. Nat Genet, 2019; 51(1):88–95.
14.
AbramovsN, BrassA, TassabehjiM. GeVIR is a continuous gene-level metric that uses variant distribution patterns to prioritize disease candidate genes. Nat Genet, 2019; 52(1):35–39.
15.
GanapathiM, PadgettLR, YamadaK, et al.Recessive rare variants in deoxyhypusine synthase, an enzyme involved in the synthesis of hypusine, are associated with a neurodevelopmental disorder. Am J Hum Genet, 2019; 104(2):287–298.
16.
ZieglerA, SteindlK, HannerAS, et al.Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder. Am J Hum Genet, 2022; 109(8):1549–1558.
17.
LiangY, PiaoC, BeuschelCB, et al.eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction. Cell Rep, 2021; 35(2):108941.
CaiH, PollardAK, CraigEL, et al.Mitochondrial complex 1 activity measured by spectrophotometry is reduced across all brain regions in ageing and more specifically in neurodegeneration. PLoS One, 2016; 11(6):e0157405.
20.
KatzeffJS, BrightF, LoK, et al.Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation. Sci Rep, 2020; 10(1):13741.
21.
MadeoF, EisenbergT, PietrocolaF, et al.Spermidine in health and disease. Science, 2018; 359(6374):eaan2788.
22.
WirthM, BensonG, SchwarzC, et al.The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial. Cortex, 2018; 109:181–188.
